Articles
-
Aug 4, 2024 |
biospace.com | Kenny Walter
On Aug. 11, the FDA is expected to make one of the year’s most highly anticipated decisions: whether or not to approve Lykos Therapeutics’ MDMA-assisted treatment for post-traumatic stress disorder. Stakeholders and industry experts recently expressed concern over the therapy, with an advisory committee recommending against its approval. Yet some are still optimistic about its potential—particularly given the continued need for new treatments for post-traumatic stress disorder (PTSD).
-
Jul 7, 2023 |
hcplive.com | Kenny Walter
-
Jul 7, 2023 |
consultantlive.com | Kenny Walter
-
Jul 7, 2023 |
consultantlive.com | Kenny Walter
-
Jul 7, 2023 |
hcplive.com | Kenny Walter
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 263
- Tweets
- 796
- DMs Open
- No
RT @michaelkohwchl: #UNC is the only ACC team to win a Final 4 game post-COVID.
RT @Andrew_Forrest1: At the 2:10 mark, Duke was up 9 and had almost a 95% win probability. Don’t ever talk about UNC’s blown halftime lea…
RT @SportsCenter: Heartbreak for the Blue Devils in the Final Four again 💔 https://t.co/q3nJHlMaHP